{"id":32727,"date":"2023-09-08T13:41:23","date_gmt":"2023-09-08T19:41:23","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=32727"},"modified":"2023-09-08T13:41:23","modified_gmt":"2023-09-08T19:41:23","slug":"brakke-viewpoint-september-8-2023","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-september-8-2023\/","title":{"rendered":"\u5e03\u62c9\u514b\u89c2\u70b9 2023 \u5e74 9 \u6708 8 \u65e5"},"content":{"rendered":"<p>\u4f34\u4fa3\u52a8\u7269\u9a71\u866b\u5242\u662f\u7f8e\u56fd\u52a8\u7269\u4fdd\u5065\u5e02\u573a\u6700\u5927\u7684\u5355\u4e00\u7ec6\u5206\u5e02\u573a\u3002\u636e\u4f30\u8ba1\uff0c\u8be5\u7ec6\u5206\u5e02\u573a\u7684\u5904\u65b9\u836f\u96f6\u552e\u989d\u7ea6\u4e3a $70 \u4ebf\u7f8e\u5143\u3002\u7531\u4e8e\u8fd9\u4e00\u5e02\u573a\u673a\u4f1a\uff0c\u8bb8\u591a\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5e0c\u671b\u521b\u65b0\u5e76\u5411\u8be5\u7ec6\u5206\u5e02\u573a\u63a8\u51fa\u65b0\u4ea7\u54c1\u548c\u65b0\u6280\u672f\u3002<\/p>\n<p>\u6700\u65b0\u5f15\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u521b\u65b0\u4ea7\u54c1\u662f\u4e09\u91cd\u7ec4\u5408\u4ea7\u54c1\uff0c\u53ea\u9700\u6bcf\u6708\u5480\u56bc\u4e00\u6b21\u5373\u53ef\u63d0\u4f9b\u65b9\u4fbf\u7684\u8df3\u86a4\u3001\u8731\u866b\u548c\u5fc3\u4e1d\u866b\u9632\u62a4\u3002Simparica Trio \u662f\u7b2c\u4e00\u4e2a\u4e0a\u5e02\u7684\u4ea7\u54c1\uff0c\u5e76\u53d6\u5f97\u4e86\u5de8\u5927\u7684\u6210\u529f\u30022023 \u5e74 7 \u6708 20 \u65e5\uff0c\u52c3\u6797\u683c\u6bb7\u683c\u7ff0\u5ba3\u5e03\u6279\u51c6 Nexgard Plus\u3002\u8fd9\u4e2a\u7ec6\u5206\u5e02\u573a\u7684\u4e0b\u4e00\u6b65\u662f\u4ec0\u4e48\uff1f<\/p>\n<p>2023 \u5e74 5 \u6708 1 \u65e5\uff0c\u9ed8\u514b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5ba3\u5e03 Bravecto Quantum \u5728\u6fb3\u5927\u5229\u4e9a\u83b7\u5f97\u6279\u51c6\uff0c\u8fd9\u662f\u9996\u6b3e\u53ef\u6ce8\u5c04\u7684\u8df3\u86a4\u548c\u8731\u866b\u4ea7\u54c1\uff0c\u53ea\u9700\u4e00\u6b21\u5242\u91cf\u5373\u53ef\u4e3a\u6211\u4eec\u6bdb\u8338\u8338\u7684\u5bb6\u5ead\u6210\u5458\u63d0\u4f9b 12 \u4e2a\u6708\u7684\u4fdd\u62a4\u3002\u4fbf\u5229\u6027\u3001\u4f9d\u4ece\u6027\u4e0e\u529f\u6548\u76f8\u7ed3\u5408\u4f3c\u4e4e\u662f\u6740\u866b\u5242\u5e02\u573a\u7684\u53d1\u5c55\u65b9\u5411\u3002Zoetis \u5728 2023 \u5e74 5 \u6708\u7684\u6295\u8d44\u8005\u65e5\u6f14\u8bb2\u4e2d\u8bc1\u5b9e\uff0c\u4ed6\u4eec\u4e5f\u5728\u7814\u53d1\u957f\u6548\u6ce8\u5c04\u4ea7\u54c1\u3002\u7ade\u4e89\u786e\u5b9e\u5f00\u59cb\u4e86\u3002<\/p>\n<p>\u6211\u4eec\u4f1a\u770b\u5230\u8fd9\u4e2a\u5de8\u5927\u7684\u5e02\u573a\u4ece\u53e3\u670d\u5230\u6ce8\u5c04\u7ed9\u836f\u7684\u8f6c\u53d8\u5417\uff1f\u8fd9\u4f1a\u5bf9\u53e3\u670d\u6216\u5916\u7528\u9a71\u866b\u5242\u96f6\u552e\u6216\u9001\u8d27\u4e0a\u95e8\u4e1a\u52a1\u4ea7\u751f\u4ec0\u4e48\u5f71\u54cd\uff1f\u6709\u9884\u6d4b\u5417\uff1f<\/p>\n<p>\u4e00\u65e6\u6ce8\u5c04\u578b\u6740\u5bc4\u751f\u866b\u5242\u5728\u7f8e\u56fd\u83b7\u51c6\u4f7f\u7528\uff0c\u60a8\u4f1a\u4ece\u53e3\u670d\u578b\u8f6c\u4e3a\u6ce8\u5c04\u578b\u6740\u8df3\u86a4\u548c\u8731\u866b\u4ea7\u54c1\u5417\uff1f<\/p>\n<p><em>\u5170\u8fea\u00b7\u5f17\u83b1\u5fb7\u65af<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>\u4f34\u4fa3\u52a8\u7269\u9a71\u866b\u836f\u662f\u7f8e\u56fd\u52a8\u7269\u4fdd\u5065\u5e02\u573a\u6700\u5927\u7684\u5355\u4e00\u7ec6\u5206\u5e02\u573a\u3002\u636e\u4f30\u8ba1\uff0c\u8be5\u7ec6\u5206\u5e02\u573a\u7684\u5904\u65b9\u836f\u96f6\u552e\u989d\u7ea6\u4e3a1470\u4ebf\u7f8e\u5143\u3002\u9274\u4e8e\u8fd9\u4e00\u5e02\u573a\u673a\u9047\uff0c\u8bb8\u591a\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u6b63\u5728\u79ef\u6781\u521b\u65b0\uff0c\u5e76\u5c06\u65b0\u4ea7\u54c1\u548c\u6280\u672f\u5f15\u5165\u8be5\u7ec6\u5206\u5e02\u573a\u3002\u6700\u65b0\u5f15\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u521b\u65b0\u4ea7\u54c1\u662f\u4e09\u91cd\u7ec4\u5408\u4ea7\u54c1\uff0c\u53ea\u9700\u6bcf\u6708\u5480\u56bc\u4e00\u6b21\u5373\u53ef\u63d0\u4f9b\u4fbf\u6377\u7684\u8df3\u86a4\u3001\u8731\u866b\u548c\u5fc3\u4e1d\u866b\u9632\u62a4\u3002Simparica Trio\u662f\u9996\u4e2a\u4e0a\u5e02\u7684\u4ea7\u54c1\uff0c\u5e76\u53d6\u5f97\u4e86\u5de8\u5927\u7684\u6210\u529f\u30022023\u5e747\u670820\u65e5\uff0c\u52c3\u6797\u683c\u6bb7\u683c\u7ff0\u5ba3\u5e03Nexgard Plus\u83b7\u6279\u3002\u8be5\u7ec6\u5206\u5e02\u573a\u7684\u4e0b\u4e00\u6b65\u53d1\u5c55\u5982\u4f55\uff1f2023\u5e745\u67081\u65e5\uff0c\u9ed8\u514b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5ba3\u5e03\u5728\u6fb3\u5927\u5229\u4e9a\u6279\u51c6Bravecto Quantum\uff0c\u8fd9\u662f\u9996\u4e2a\u53ef\u6ce8\u5c04\u7684\u8df3\u86a4\u548c\u8731\u866b\u4ea7\u54c1\uff0c\u53ea\u9700\u4e00\u6b21\u5242\u91cf\u5373\u53ef\u4e3a\u6211\u4eec\u6bdb\u8338\u8338\u7684\u5bb6\u5ead\u6210\u5458\u63d0\u4f9b12\u4e2a\u6708\u7684\u4fdd\u62a4\u3002\u4fbf\u6377\u6027\u3001\u4f9d\u4ece\u6027\u4e0e\u6709\u6548\u6027\u7684\u7ed3\u5408\u4f3c\u4e4e\u662f\u9a71\u866b\u836f\u5e02\u573a\u7684\u53d1\u5c55\u65b9\u5411\u3002\u7855\u817e\u57282023\u5e745\u6708\u7684\u6295\u8d44\u8005\u65e5\u6f14\u8bb2\u4e2d\u786e\u8ba4\uff0c\u4ed6\u4eec\u4e5f\u5728\u7814\u53d1\u957f\u6548\u6ce8\u5c04\u5242\u4ea7\u54c1\u3002\u7ade\u4e89\u786e\u5b9e\u5df2\u7ecf\u5f00\u59cb\u3002\u6211\u4eec\u4f1a\u770b\u5230\u8fd9\u4e2a\u5de8\u5927\u7684\u5e02\u573a\u4ece\u53e3\u670d\u7ed9\u836f\u8f6c\u5411\u6ce8\u5c04\u7ed9\u836f\u5417\uff1f\u8fd9\u4f1a\u5bf9\u53e3\u670d\u6216\u5916\u7528\u9a71\u866b\u836f\u7684\u96f6\u552e\u6216\u9001\u8d27\u4e0a\u95e8\u4e1a\u52a1\u4ea7\u751f\u4ec0\u4e48\u5f71\u54cd\uff1f\u6709\u9884\u6d4b\u5417\uff1f<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-september-8-2023\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-32727","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-september-8-2023\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"Companion animal parasiticides represent the single largest market segment in the US Animal Health market.\u00a0 Estimates peg the prescription portion of this market segment at approximately $7.0 billion at the retail level.\u00a0 As a result of this market opportunity, many of the animal health companies look to innovate and introduce new products and technologies into this segment. The latest innovation introduced into the US market are triple combination products providing convenient flea, tick and heartworm protection in a single monthly chew.\u00a0 Simparica Trio was the first to market and has been a huge success.\u00a0 On July 20, 2023, Boehringer announced the approval of Nexgard Plus.\u00a0 What\u2019s next in this market segment? On May 1, 2023, Merck Animal Health announced the approval of Bravecto Quantum in Australia, the first injectable flea and tick product, providing 12 months of coverage with a single dose to our furry family members.\u00a0 Convenience, compliance combined with efficacy appears to be the direction that the parasiticide market is headed.\u00a0 Zoetis confirmed in their May 2023 investor day presentation that they are also working on long-acting injectable products.\u00a0 The race is indeed on. Will we see the transformation of this huge market from oral to injectable administration?\u00a0 What will this do to the oral or topical parasiticides retail or home delivery business?\u00a0 Have a crystal ball? WillView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-september-8-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-08T19:41:23+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Viewpoint September 8, 2023\",\"datePublished\":\"2023-09-08T19:41:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/\"},\"wordCount\":240,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\"},\"datePublished\":\"2023-09-08T19:41:23+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/ja\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Viewpoint September 8, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-september-8-2023\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"Companion animal parasiticides represent the single largest market segment in the US Animal Health market.\u00a0 Estimates peg the prescription portion of this market segment at approximately $7.0 billion at the retail level.\u00a0 As a result of this market opportunity, many of the animal health companies look to innovate and introduce new products and technologies into this segment. The latest innovation introduced into the US market are triple combination products providing convenient flea, tick and heartworm protection in a single monthly chew.\u00a0 Simparica Trio was the first to market and has been a huge success.\u00a0 On July 20, 2023, Boehringer announced the approval of Nexgard Plus.\u00a0 What\u2019s next in this market segment? On May 1, 2023, Merck Animal Health announced the approval of Bravecto Quantum in Australia, the first injectable flea and tick product, providing 12 months of coverage with a single dose to our furry family members.\u00a0 Convenience, compliance combined with efficacy appears to be the direction that the parasiticide market is headed.\u00a0 Zoetis confirmed in their May 2023 investor day presentation that they are also working on long-acting injectable products.\u00a0 The race is indeed on. Will we see the transformation of this huge market from oral to injectable administration?\u00a0 What will this do to the oral or topical parasiticides retail or home delivery business?\u00a0 Have a crystal ball? WillView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-september-8-2023\/","og_site_name":"Brakke Consulting Website","article_published_time":"2023-09-08T19:41:23+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Amanda McDavid","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Viewpoint September 8, 2023","datePublished":"2023-09-08T19:41:23+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/"},"wordCount":240,"articleSection":["Viewpoints"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/","url":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#website"},"datePublished":"2023-09-08T19:41:23+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-september-8-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Brakke Viewpoint September 8, 2023"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/ja\/#website","url":"https:\/\/brakkeconsulting.com\/ja\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"\u963f\u66fc\u8fbe\u00b7\u9ea6\u514b\u6234\u7ef4","url":"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/32727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=32727"}],"version-history":[{"count":2,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/32727\/revisions"}],"predecessor-version":[{"id":32730,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/32727\/revisions\/32730"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=32727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=32727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=32727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}